Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.

Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A.

J Infect Dis. 2009 Dec 1;200(11):1746-54. doi: 10.1086/644785.

PMID:
19874178
[PubMed - indexed for MEDLINE]
Free Article
2.

Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report.

Di Biagio A, Rosso R, Monteforte P, Russo R, Rovetta G, Viscoli C.

J Med Case Rep. 2009 Jul 22;3:8136. doi: 10.4076/1752-1947-3-8136.

PMID:
19830218
[PubMed]
Free PMC Article
3.

Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.

Lebrecht D, Venhoff AC, Kirschner J, Wiech T, Venhoff N, Walker UA.

J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):258-63.

PMID:
19582894
[PubMed - indexed for MEDLINE]
4.

Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.

Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J.

Biol Pharm Bull. 2009 Jul;32(7):1193-8.

PMID:
19571384
[PubMed - indexed for MEDLINE]
Free Article
5.

Severe osteomalacia presenting with multiple vertebral fractures: a case report and review of the literature.

Ukinc K.

Endocrine. 2009 Aug;36(1):30-6. doi: 10.1007/s12020-009-9209-8. Epub 2009 Jun 19. Review.

PMID:
19543841
[PubMed - indexed for MEDLINE]
6.

Tenofovir-associated renal and bone toxicity.

Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D, Edwards SG, Johnson MA, Connolly JO.

HIV Med. 2009 Sep;10(8):482-7. doi: 10.1111/j.1468-1293.2009.00716.x. Epub 2009 May 6.

PMID:
19459988
[PubMed - indexed for MEDLINE]
7.

Mechanisms of antiretroviral therapy-induced mitochondrial dysfunction.

Côté HC.

Curr Opin HIV AIDS. 2007 Jul;2(4):253-60. doi: 10.1097/COH.0b013e3281df3410.

PMID:
19372896
[PubMed]
8.

Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.

Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, Chen D, Weinstein J, Shore J, da Silva B, Belsey E, McComsey GA, Murphy RL.

J Antimicrob Chemother. 2009 Jun;63(6):1244-50. doi: 10.1093/jac/dkp100. Epub 2009 Mar 25.

PMID:
19321503
[PubMed - indexed for MEDLINE]
Free Article
9.

Tenofovir renal toxicity targets mitochondria of renal proximal tubules.

Kohler JJ, Hosseini SH, Hoying-Brandt A, Green E, Johnson DM, Russ R, Tran D, Raper CM, Santoianni R, Lewis W.

Lab Invest. 2009 May;89(5):513-9. doi: 10.1038/labinvest.2009.14. Epub 2009 Mar 9.

PMID:
19274046
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.

Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C.

J Clin Rheumatol. 2009 Mar;15(2):72-4. doi: 10.1097/RHU.0b013e31819c20d8.

PMID:
19265350
[PubMed - indexed for MEDLINE]
11.

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.

Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, Rivas P, Albalater M, Blanco F, Moreno V, Vispo E, Soriano V.

AIDS. 2009 Mar 27;23(6):689-96. doi: 10.1097/QAD.0b013e3283262a64.

PMID:
19262355
[PubMed - indexed for MEDLINE]
12.

Glucocorticoids and the risk of osteoporosis.

Caplan L, Saag KG.

Expert Opin Drug Saf. 2009 Jan;8(1):33-47. doi: 10.1517/14740330802648194 . Review.

PMID:
19236216
[PubMed - indexed for MEDLINE]
13.

Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).

Ribera E, Paradiñeiro JC, Curran A, Sauleda S, García-Arumí E, Castella E, Puiggròs C, Crespo M, Feijoo M, Diaz M, Del Saz SV, Planas M, Sureda D, Falcó V, Ocaña I, Pahissa A.

HIV Clin Trials. 2008 Nov-Dec;9(6):407-17. doi: 10.1310/hct0906-407.

PMID:
19203906
[PubMed - indexed for MEDLINE]
14.

Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.

Fux CA, Rauch A, Simcock M, Bucher HC, Hirschel B, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Elzi L, Furrer H; Swiss HIV Cohort Study.

Antivir Ther. 2008;13(8):1077-82.

PMID:
19195333
[PubMed - indexed for MEDLINE]
15.

Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdal MA, Henriksen K.

Hum Genet. 2009 Jan;124(6):561-77. doi: 10.1007/s00439-008-0583-8. Epub 2008 Nov 6. Review.

PMID:
18987890
[PubMed - indexed for MEDLINE]
16.

Osteoporosis: an age-related and gender-specific disease--a mini-review.

Pietschmann P, Rauner M, Sipos W, Kerschan-Schindl K.

Gerontology. 2009;55(1):3-12. doi: 10.1159/000166209. Epub 2008 Oct 24. Review.

PMID:
18948685
[PubMed - indexed for MEDLINE]
17.

Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice.

Desai VG, Lee T, Moland CL, Branham WS, Von Tungeln LS, Beland FA, Fuscoe JC.

Mitochondrion. 2009 Feb;9(1):9-16. doi: 10.1016/j.mito.2008.09.002. Epub 2008 Sep 13.

PMID:
18824140
[PubMed - indexed for MEDLINE]
18.

Tenofovir: what have over 1 million years of patient experience taught us?

Pozniak A.

Int J Clin Pract. 2008 Aug;62(8):1285-93. doi: 10.1111/j.1742-1241.2008.01817.x. Review.

PMID:
18705824
[PubMed - indexed for MEDLINE]
19.

Vitamin D deficiency in children and its management: review of current knowledge and recommendations.

Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.

Pediatrics. 2008 Aug;122(2):398-417. doi: 10.1542/peds.2007-1894. Review.

PMID:
18676559
[PubMed - indexed for MEDLINE]
Free Article
20.

Experience with tenofovir disoproxil fumarate for antiretroviral therapy.

Stephan C.

Expert Opin Pharmacother. 2008 May;9(7):1197-209. doi: 10.1517/14656566.9.7.1197. Review.

PMID:
18422476
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk